MeSH Browser

MeSH Heading: Multiple Sclerosis
Tree Number(s): C10.114.375.500; C10.314.350.500; C20.111.258.250.500
Unique ID: D009103
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D009103
Scope Note: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Entry Term(s): MS (Multiple Sclerosis); Multiple Sclerosis, Acute Fulminating; Sclerosis, Disseminated
NLM Classification #: WL 360
See Also: Myelitis, Transverse
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2010/06/25

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0014197
Scope Note: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Terms: Multiple Sclerosis Preferred Term
Term UI T027212
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1966); MS (Multiple Sclerosis)
Term UI T366472
Date11/03/1999
LexicalTag NON
ThesaurusID NLM (2000); Sclerosis, Disseminated
Term UI T027213
Date03/30/1974
LexicalTag NON
ThesaurusID UNK (19XX)

Multiple Sclerosis MeSH Descriptor Data 2024